<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="other" dtd-version="1.2" xml:lang="en">
    <front>
        <journal-meta>
            <journal-id journal-id-type="pmc">F1000Research</journal-id>
            <journal-title-group>
                <journal-title>F1000Research</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2046-1402</issn>
            <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.12688/f1000research.153895.1</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Opinion Article</subject>
                </subj-group>
                <subj-group>
                    <subject>Articles</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>From the establishment of a national bioinformatics society to the development of a national bioinformatics infrastructure</article-title>
                <fn-group content-type="pub-status">
                    <fn>
                        <p>[version 1; peer review: 3 approved with reservations]</p>
                    </fn>
                </fn-group>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Mir&#x0103;u&#x021b;&#x0103;</surname>
                        <given-names>Bogdan</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Funding Acquisition</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-9733-292X</uri>
                    <xref ref-type="corresp" rid="c1">a</xref>
                    <xref ref-type="aff" rid="a1">1</xref>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Zenoaga-Barb&#x0103;ro&#x0219;ie</surname>
                        <given-names>C&#x0103;t&#x0103;lina</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                    <xref ref-type="aff" rid="a3">3</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Abrudan</surname>
                        <given-names>Monica</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a4">4</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Mih&#x0103;&#x0219;an</surname>
                        <given-names>Marius</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a2">2</xref>
                    <xref ref-type="aff" rid="a5">5</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Giurgiu</surname>
                        <given-names>M&#x0103;d&#x0103;lina</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0001-5007-7442</uri>
                    <xref ref-type="aff" rid="a2">2</xref>
                    <xref ref-type="aff" rid="a6">6</xref>
                    <xref ref-type="aff" rid="a7">7</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Mihalachi</surname>
                        <given-names>Daria</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <xref ref-type="aff" rid="a8">8</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Laz&#x0103;r</surname>
                        <given-names>Michalis-Daniel</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <xref ref-type="aff" rid="a8">8</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                    <collab>RSBI Members</collab>
                    <xref ref-type="corresp" rid="c2">b</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Banciu</surname>
                        <given-names>Horia L.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-6563-3226</uri>
                    <xref ref-type="aff" rid="a2">2</xref>
                    <xref ref-type="aff" rid="a8">8</xref>
                </contrib>
                <aff id="a1">
                    <label>1</label>Romanian Bioinformatics Cluster, T&#x00e2;rgu Mure&#x0219;, Romania</aff>
                <aff id="a2">
                    <label>2</label>Romanian Society of Bioinformatics, Cluj-Napoca, Romania</aff>
                <aff id="a3">
                    <label>3</label>Department of Genetics, Faculty of Biology, University of Bucharest, Bucharest, Romania</aff>
                <aff id="a4">
                    <label>4</label>Centre for Genomic Pathogen Surveillance, Pandemic Sciences Institute, University of Oxford, Oxford, England, UK</aff>
                <aff id="a5">
                    <label>5</label>Biology Department, Alexandru Ioan Cuza University of Ia&#x0219;i, Ia&#x0219;i, Romania</aff>
                <aff id="a6">
                    <label>6</label>Free University of Berlin, Berlin, Germany</aff>
                <aff id="a7">
                    <label>7</label>Department of Pediatric Oncology and Hematology, Charit&#x00e9; &#x2013; Universit&#x00e4;tsmedizin Berlin, Berlin, Germany</aff>
                <aff id="a8">
                    <label>8</label>Department of Molecular Biology and Biotechnology, Faculty of Biology and Geology, Babe&#x0219;-Bolyai University, Cluj-Napoca, Romania</aff>
            </contrib-group>
            <author-notes>
                <corresp id="c1">
                    <label>a</label>
                    <email xlink:href="mailto:bogdan.mirauta@bioinfocluster.ro">bogdan.mirauta@bioinfocluster.ro</email>
                </corresp>
                <corresp id="c2">
                    <label>b</label>
                    <email xlink:href="mailto:contact@rsbi.ro">contact@rsbi.ro</email>
                </corresp>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>The authors declare that they have affiliations and memberships with organisations related to the content of this publication. All authors are members or associated members of the Romanian Society of Bioinformatics (RSBI). MM and MG serve as Board members of RSBI. HLB and MM are faculty members at universities that are founding members of the Romanian Bioinformatics Cluster (CRB). BM, HLB, and MM are Board members of CRB. At the time of manuscript submission, MA is employed by EMBL, an intergovernmental organisation part of ELIXIR. These relationships have been fully disclosed and are not deemed to interfere with the objectivity and integrity of the opinions presented in this manuscript. </p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>3</day>
                <month>9</month>
                <year>2024</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2024</year>
            </pub-date>
            <volume>13</volume>
            <elocation-id>1002</elocation-id>
            <history>
                <date date-type="accepted">
                    <day>23</day>
                    <month>8</month>
                    <year>2024</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2024 Mir&#x0103;u&#x021b;&#x0103; B et al.</copyright-statement>
                <copyright-year>2024</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <self-uri content-type="pdf" xlink:href="https://f1000research.com/articles/13-1002/pdf"/>
            <abstract>
                <p>We describe the evolution of a bioinformatics national capacity from scattered professionals into a collaborative organisation, and advancements in the adoption of the bioinformatics infrastructure philosophy by the national community.</p>
                <p>The Romanian Society of Bioinformatics (RSBI), a national professional society, was founded in 2019 to accelerate the development of Romanian bioinformatics. Incrementally, RSBI expanded its role to include: i) developing a community and engaging the public and stakeholders, ii) a national training approach, including through increased interactions with European training resources, and iii) advocating national participation in European bioinformatics infrastructures. In a next step RSBI led the development of the national bioinformatics infrastructure, the Romanian Bioinformatics Cluster (CRB) with the mission to act as an ELIXIR National Node.</p>
                <p>In this paper we report both the successful projects in training, public engagement, and policy projects, as well as initiatives related to data federation that, while not successful, can serve as valuable learning experiences for future implementations.</p>
                <p>We explain CRB&#x2019;s structure and the role such an entity can play in the national bioinformatics infrastructure for data, tools, and training. Finally, we offer insights into the evolving role of the bioinformatics professional society and the synergies and interactions with the National ELIXIR Node</p>
            </abstract>
            <kwd-group kwd-group-type="author">
                <kwd>bioinformatics society</kwd>
                <kwd>ELIXIR</kwd>
                <kwd>FAIR</kwd>
                <kwd>training</kwd>
                <kwd>public engagement</kwd>
            </kwd-group>
            <funding-group>
                <award-group id="fund-1">
                    <funding-source>EEA Grants/Norway Grants (Bioinformatics Capacity Building Human Genomics, an RSBI and ELIXIR Norway bilateral project)</funding-source>
                    <award-id>2/2022</award-id>
                </award-group>
                <funding-statement>The workshops organised by RSBI between 2022 and 2024 were partially funded through the Bioinformatics Capacity Building Human Genomics project, a bilateral project organised by the Romanian Society of Bioinformatics in collaboration with ELIXIR Norway, funded through the Bilateral Fund associated with the EEA and Norwegian Grants 2014-2021, and administered by UEFISCDI, as Research Program Operator in Romania (Grant 2/2022).</funding-statement>
                <funding-statement>
                    <italic>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</italic>
                </funding-statement>
            </funding-group>
        </article-meta>
    </front>
    <body>
        <sec id="sec1" sec-type="intro">
            <title>Introduction</title>
            <p>The need for centralised data resources and bioinformatics services prompted the development of dedicated infrastructures. The establishment in 1994 of the European Bioinformatics Institute (EMBL-EBI), an outstation of European Molecular Biology Laboratory (EMBL) was followed by the development of bioinformatics networks and national bioinformatics infrastructures in most European countries. These infrastructures encompass resources and services that are organised and coordinated at a country level, and aim to provide the necessary tools, resources, and expertise to researchers and organisations within a country. The infrastructures include several key components: collaboration and networking, data, software, computing resources, training, support, ELSI (Ethical, Legal and Societal Implications) and outreach.</p>
            <p>In a second phase, the increasing need to have synchronised approaches across Europe led to the development of the distributed infrastructure for life-science data (ELIXIR) (
                <xref ref-type="bibr" rid="ref4">Crosswell and Thornton, 2012</xref>; 
                <xref ref-type="bibr" rid="ref17">Harrow et al., 2021</xref>). ELIXIR was developed as a project in 2006 and became an ESFRI (European Strategy Forum on Research and Innovation) landmark in 2016. ELIXIR brings together national centres across Europe into a coordinated infrastructure for bioinformatics.</p>
            <p>The relevance of such organisations became obvious during the COVID-19 pandemic, as nations urgently depended on them to access analysis pipelines and efficiently manage data. Currently, large scale European projects, such as the European Genomic Data Infrastructure (GDI) and EOSC-ENTRUST, rely on these structures for their European and national reach. In addition, while the bioinformatics ecosystem has increasingly embraced the FAIR (Findable, Accessible, Interoperable, and Reusable) principles for data (
                <xref ref-type="bibr" rid="ref21">Rocca-Serra et al., 2023</xref>; 
                <xref ref-type="bibr" rid="ref34">Wilkinson et al., 2016</xref>), software (
                <xref ref-type="bibr" rid="ref2">Barker et al., 2022</xref>; 
                <xref ref-type="bibr" rid="ref14">Goble et al., 2020</xref>; 
                <xref ref-type="bibr" rid="ref19">Patel et al., 2023</xref>), and training (
                <xref ref-type="bibr" rid="ref12">Garcia et al., 2020</xref>), the effective implementation of these principles remains challenging. The national bioinformatics infrastructures were identified to be adequate mechanisms to overcome these challenges (
                <xref ref-type="bibr" rid="ref30">Soranzo and Goble, 2023</xref>).</p>
            <p>A keystone of national bioinformatics infrastructures, the national professional organisations in bioinformatics play roles in networking facilitation, training or job placement. Importantly, through the implicit national representation, these professional organisations can ethically advocate the interests of the profession, broaden participation, drive change, develop and deploy standards and ethical guidelines. (
                <xref ref-type="bibr" rid="ref18">Mourad et al., 2018</xref>; 
                <xref ref-type="bibr" rid="ref31">Suddaby et al., 2002</xref>). Bioinformatics professional organisations exist in most European countries, although their role depends on national circumstances. Guidelines on how to establish bioinformatics communities and scientific professional societies can be found in (
                <xref ref-type="bibr" rid="ref3">Budd et al., 2015</xref>) and (
                <xref ref-type="bibr" rid="ref11">Ga&#x00eb;ta et al., 2017</xref>).</p>
            <p>We present in this paper the priming and evolution of the bioinformatics community and ecosystem in Romania between 2017 and 2024. We describe how the Romanian bioinformatics community evolved into an established national society - the Romanian Society of Bioinformatics (RSBI), the process of preparing a national bioinformatics infrastructure and the steps towards Romania&#x2019;s ELIXIR Membership.</p>
        </sec>
        <sec id="sec2">
            <title>Establishment of a professional society in bioinformatics in Romania</title>
            <p>The RSBI was established as a bioinformatics professional society following a preparation phase that started in 2017 with a mission to enhance Romania&#x2019;s bioinformatics capacity. At that time, Romania lacked the critical mass necessary to develop self-sustaining bioinformatics programs and had minimal collaborations among bioinformatics groups across the country.</p>
            <p>The development of the bioinformatics community into a national society was closely tied to a series of bioinformatics workshops organised by the founding group. By co-organising workshops in partnership with various host organisations, and establishing a presence in different academic centres (Bucharest, Cluj-Napoca, Ia&#x015f;i, Timi&#x015f;oara), RSBI achieved widespread national distribution and facilitated connections among scientists from its inception.</p>
            <p>RSBI officially came into existence in 2019, following the approval by the Romanian Government for RSBI to adopt the national reference, an approval given after the founding community demonstrated national representation. Importantly, the development of the society and the Bylaws of Association were freely debated among the founding members of the association.</p>
            <p>Right from the start, RSBI prioritised transparency, a sense of ethics, and achieving a balanced geographical, academic and gender representation. Of note, the initial development was facilitated by a strong involvement of the Romanian diaspora from the Wellcome Sanger Institute and the European Bioinformatics Institute, UK.</p>
            <p>RSBI is governed by a board of up to 6 members. Among these members, one serves as the legal representative. The board is chosen by the General Assembly through a voting process, an anonymous voting procedure being adopted starting April 2024.</p>
            <p>The society fosters continuous communication among its members, recognizing it as a fundamental aspect of its operations. This communication is facilitated through an email group as well as monthly meetings. Additionally, RSBI ensures engagement with stakeholders and the public through active management of social media accounts (
                <xref ref-type="bibr" rid="ref23">RSBI, 2018a</xref>, 
                <xref ref-type="bibr" rid="ref24">2018b</xref>)</p>
            <sec id="sec3">
                <title>Core activities of RSBI</title>
                <p>RSBI&#x2019;s initial objectives were to run bioinformatics training at national scale and organise the community so it can provide support to the development of academic bioinformatics training. Although the training events remained the core activity, RSBI developed as a proactive organisation, taking additional roles in building the Romanian bioinformatics ecosystem through engagement with the public and advocacy for infrastructure and policy development (
                    <xref ref-type="fig" rid="f1">Figure 1</xref>).</p>
                <fig fig-type="figure" id="f1" orientation="portrait" position="float">
                    <label>Figure 1. </label>
                    <caption>
                        <title>Time-line of RSBI activities.</title>
                        <p>Following an initial emphasis on training and public engagement events, RSBI has assumed roles in advocating Romania&#x2019;s participation in European initiatives and the development of the national bioinformatics infrastructure CRB. The RoBioinfo Seminars started in 2018, and, since then, RSBI organised more than 30 training and 20 public engagement events. The infrastructure development campaigns included multiple communications campaigns addressed to public administration officials and extensive communication campaigns to the research community. Abbreviations: SRGM - Societatea Rom&#x00e2;n&#x0103; de Genetic&#x0103; Medical&#x0103; (Romanian Society for Medical Genetics), FEGA - Federated European Genome-phenome Archive, RSBI - Romanian Society of Bioinformatics.</p>
                    </caption>
                    <graphic id="gr1" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/168851/0af444db-9953-42ee-a490-174351d25ce6_figure1.gif"/>
                </fig>
                <p>Training</p>
                <p>The RoBioinfo Seminars, a national bioinformatics training programme (30+ events; Extended data 1), owe much of the initial development to the support provided by groups from EMBL-EBI Training, Ensembl Training, Polish Bioinformatics Society (PTBI), Italian Bioinformatics Society (BITS), and the Hungarian ELIXIR Node. The initial collaborations, coupled with a proactive communication campaign, resulted in an average pre-pandemic participation rate of 20% from neighbouring countries to the RoBioinfo Seminars. In addition to their technical substance, the in-person RoBioinfo Seminars are notable for fostering a scientific and inclusive atmosphere, providing an opportunity for Romanian bioinformaticians to meet and facilitating the development of the national network.</p>
                <p>From 2022 to 2024, through bilateral cooperation with ELIXIR Norway, funded by a grant from the Bilateral Fund associated with the EEA and Norwegian Grants 2014-2021, the focus of the workshops expanded to include new topics such as data federation and scientific workflow systems. In 2023, RSBI initiated the annual RoBioinfo Conferences as part of the same project.</p>
                <p>Public engagement</p>
                <p>Public engagement has been from the very beginning a substantial part of RSBI&#x2019;s philosophy. Following the model of previously tested initiatives (
                    <xref ref-type="bibr" rid="ref13">Georgescu, 2023</xref>), RSBI organised several &#x201c;Beer and Science&#x201d; and &#x201c;Science in schools&#x201d; events. Initially a satellite event to the RoBioinfo Seminars, &#x201c;Beer and Science&#x201d; has since evolved into standalone events. While open to the public, their primary aim remains fostering connections among students, young and established scientists across various disciplines, research groups and scientific interests. We provide in Extended data 2 the RSBI perspective and toolkit for organising Beer and Science events. Importantly, these events had the desired secondary effect of developing a sense of community and social impact within the organisation.</p>
                <p>Furthermore, RSBI has also actively contributed to informing the general public on topics of high interest. During the COVID-19 crisis RSBI collaborated with the Romanian Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI) to better inform the general public (
                    <xref ref-type="bibr" rid="ref33">UEFISCDI, 2020</xref>). RSBI also developed information leaflets for public and general medical practitioners on the relevance of federating genomics data (Extended data 3). Importantly, as RSBI is an organisation of scientists, achieving sustained communication with the general public on a large scale can only be accomplished through collaborations with other organisations.</p>
                <p>Policy</p>
                <p>RSBI has actively contributed to the reform of public policies in genomics and bioinformatics. This involvement includes contributing to the development of national research strategies in life sciences and digitalization, as well as advocating for participation in European initiatives on genomics and bioinformatics. Following an organic approach, RSBI has worked to raise awareness and gather feedback within the scientific community. Subsequently, this feedback has been passed to policymakers, aiming to ensure that perspectives from relevant stakeholders are considered in the policymaking process.</p>
                <p>For this purpose RSBI co-organised a series of webinars targeting the research community (
                    <xref ref-type="bibr" rid="ref9">ELIXIR, 2024</xref>, 
                    <xref ref-type="bibr" rid="ref7">2020</xref>) and has disseminated information to the public through press releases, radio interventions and social media, (e.g. (
                    <xref ref-type="bibr" rid="ref25">RSBI, 2023</xref>)).</p>
                <p>RSBI then engaged with the Romanian Ministry of Research, Innovation and Digitalization (MCID) on matters concerning human genomics and bioinformatics in general. Recognizing the importance of grounding political actions in research realities, RSBI documented and presented to political representatives the scientific motivation for national level approaches to genomics, the opportunities provided by the European bioinformatics infrastructure, and drawbacks of non-participation in such initiatives.</p>
                <p>Building upon the groundwork laid by RSBI between 2020 and 2023, and with proactive involvement from the University of Medicine and Pharmacy &#x201c;Carol Davila&#x201d;, Bucharest, MCID made the decision in 2023 to sign the &#x2018;1+ Million Genomes&#x2019; (1+MG) European initiative (
                    <xref ref-type="bibr" rid="ref22">Romanian Government, 2023</xref>) and join the European bioinformatics infrastructure - ELIXIR (
                    <xref ref-type="bibr" rid="ref8">ELIXIR, 2023</xref>).</p>
                <p>Attempts towards data federation</p>
                <p>Efforts towards data federation in Romania, led by RSBI, did not yield similar levels of success as of above-mentioned initiatives (Extended data 4). While there is recognition of the importance of integrating individual contributions into major European data initiatives like the COVID-19 Data Portal (
                    <xref ref-type="bibr" rid="ref16">Harrison et al., 2021</xref>) or the Federated European Genome-phenome Archive (FEGA) (
                    <xref ref-type="bibr" rid="ref10">Freeberg et al., 2021</xref>), insufficient resources and incentives hindered active participation and contribution from individual groups.</p>
                <p>Despite their slow development, adopting data federation in some form, and establishing the necessary data structures are crucial for numerous research projects. This underscores the significance of having national bioinformatics infrastructures capable of implementing data solutions on a national level and providing support to research groups.</p>
            </sec>
            <sec id="sec4">
                <title>Conclusions on the establishment of the national professional society</title>
                <p>The principles described in (
                    <xref ref-type="bibr" rid="ref3">Budd et al., 2015</xref>) and (
                    <xref ref-type="bibr" rid="ref11">Ga&#x00eb;ta et al., 2017</xref>) proved to be important for the development of RSBI. The clear mission, the commitment to inclusivity, a positive work environment, and the recognition of contributions attracted a substantial number of contributors. The organisation has evolved based on feedback from its members. For instance, suggestions regarding the need for consistent communication were implemented, resulting in the establishment of monthly RSBI meetings. Of note, sustaining and developing a professional society requires significant community management effort, an activity that usually goes beyond expected voluntary academic involvement. As also mentioned in (
                    <xref ref-type="bibr" rid="ref3">Budd et al., 2015</xref>), appropriate compensation for community managers would be a mechanism to ensure sustainability.</p>
                <p>Importantly, given the ongoing development of the field and the ubiquitous large national genomics programs, a national bioinformatics society can have a significant impact. To maximise this impact, we add to the previous guidelines the recommendation of 1) establishing working relationships with the public administration and 2) identifying the overlaps and synergies with the bioinformatics infrastructures, e.g. with the National ELIXIR Nodes.</p>
            </sec>
        </sec>
        <sec id="sec81">
            <title>Towards the national bioinformatics infrastructure - the Romanian Bioinformatics Cluster</title>
            <p>Recognizing the deficiencies in both data and training infrastructure, RSBI suggested to the national community the development of an entity capable of conducting nationwide activities to address these challenges.</p>
            <p>Following a thorough consultation period within the research community, the Romanian Bioinformatics Cluster, or &#x201c;Clusterul Rom&#x00e2;n de Bioinformatic&#x0103;&#x201d; in Romanian, hereon CRB, was established in 2022 by seventeen universities and research and medical organisations in collaboration with two national professional organisations (
                <xref ref-type="fig" rid="f2">Figure 2</xref>; 
                <ext-link ext-link-type="uri" xlink:href="https://bioinfocluster.ro/">https://bioinfocluster.ro/</ext-link>). CRB operates as a not-for-profit entity with legal status and a federated structure. Its organisational model draws inspiration from national ELIXIR consortia.</p>
            <fig fig-type="figure" id="f2" orientation="portrait" position="float">
                <label>Figure 2. </label>
                <caption>
                    <title>Development and structure of CRB.</title>
                    <p>A) Steps followed in creating a functional ELIXIR Node, starting with community consultation in 2022 the governmental decision to submit the membership request in April 2024 and culminating with Romania's application being approved by the ELIXIR Board in June 2024. The diagram highlights the critical importance of three aspects for a functional ELIXIR Node: community involvement, recruitment of coordinators for data, tools, and training, and engagement with the government. b) Distribution of CRB founding members across Romania: many of the major Romanian research centres and the two professional societies are represented in CRB.</p>
                </caption>
                <graphic id="gr2" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/168851/0af444db-9953-42ee-a490-174351d25ce6_figure2.gif"/>
            </fig>
            <p>CRB is governed by the General Assembly of Members, in which each member institution has a representative and an executive body, the Board of Directors. The Board of Directors is elected for a 2-year mandate, an anonymous nomination and voting procedure being implemented starting May 2024. The daily administration is carried out by an Administrative Entity, currently &#x201c;G. E. Palade&#x201d; University of Medicine, Pharmacy, Science and Technology of T&#x00e2;rgu Mure&#x015f;.</p>
            <p>The primary objectives of CRB include:
                <list list-type="bullet">
                    <list-item>
                        <label>&#x2022;</label>
                        <p>
                            <bold>A framework for the development of national bioinformatics training and training resources</bold>. This entails backing programs conducted by RSBI, as well as contributing to the development and upkeep of bioinformatics training resources, and facilitating the training delivery. In practice, within the framework developed by the ELIXIR Training Platform, this will consist in the development of an eLearning ecosystem, supporting the implementation of the FAIR-ification (
                            <xref ref-type="bibr" rid="ref12">Garcia et al., 2020</xref>) of training materials, and supporting the train-the-trainer programmes in bioinformatics.</p>
                    </list-item>
                    <list-item>
                        <label>&#x2022;</label>
                        <p>
                            <bold>Increase the value of data through the development of data infrastructures</bold>. CRB aims to facilitate the development of data infrastructures for molecular data by supporting research organisations in deploying national instances of data structures (eg. portals for pathogen data (
                            <xref ref-type="bibr" rid="ref16">Harrison et al., 2021</xref>) or human data (
                            <xref ref-type="bibr" rid="ref10">Freeberg et al., 2021</xref>)), implementing novel techniques to data sharing (
                            <xref ref-type="bibr" rid="ref1">Amid et al., 2019</xref>) and ensuring uniform access, e.g. by building on the 
                            <ext-link ext-link-type="uri" xlink:href="https://www.eosc-life.eu/news/launch-of-ls-login/">the LS Login authentication service from EOSC-Life</ext-link>.</p>
                    </list-item>
                    <list-item>
                        <label>&#x2022;</label>
                        <p>
                            <bold>Ease the choice and use of bioinformatics tools</bold>. CRB will aim to achieve this by implementing a distributed help desk system and by supporting the development of a national bioinformatics software ecosystem integrated in the European framework. This will build on advancements in scientific workflow managers (
                            <xref ref-type="bibr" rid="ref5">Crusoe et al., 2022</xref>; 
                            <xref ref-type="bibr" rid="ref6">Di Tommaso et al., 2017</xref>; 
                            <xref ref-type="bibr" rid="ref15">Goble et al., 2021</xref>; 
                            <xref ref-type="bibr" rid="ref32">The Galaxy Community, 2022</xref>), software benchmarking (
                            <xref ref-type="bibr" rid="ref20">Pico et al., 2022</xref>) and European projects aimed at developing an integrated ecosystem, e.g. 
                            <ext-link ext-link-type="uri" xlink:href="https://research-software-ecosystem.github.io/">https://research-software-ecosystem.github.io/</ext-link>. The support will include contributions to European initiatives, engaging the national community to adopt these advancements, and launching or supporting relevant national instances.</p>
                    </list-item>
                </list>
            </p>
            <p>Thanks to its federated structure and strong interaction within ELIXIR, CRB possesses the necessary mechanisms to assist member universities and other national research centres in adopting best practices and adhering to standards. This is particularly significant given that new projects in life sciences are slated for funding in Romania in 2024, and Romania expanded its participation in European research infrastructures through the development of National Nodes for ERIC-MIRRI (Observership; 2023) and Genomic Data Infrastructure (Onboarding; 2024). Harmonising the bioinformatics outcomes and addressing the technical and differing issues to achieve functional interoperability requires inter-institutional approaches, such as those enabled through the CRB structure.</p>
        </sec>
        <sec id="sec5">
            <title>Discussions - an evolving bioinformatics ecosystem in Romania</title>
            <p>The initial phase of RSBI&#x2019;s development was driven by a pressing need to start bioinformatics training, foster a sense of community, advocate for the importance of this profession, and contribute to the establishment of a country-wide network of bioinformaticians.</p>
            <p>The present and forthcoming period for the Romanian life sciences is marked by the implementation or planning of several large-scale projects requiring bioinformatics, and Romania&#x2019;s integration into the broader European bioinformatics ecosystem. Coinciding with these developments, RSBI approached a maturity stage, a stage in which its role as a professional organisation is evolving.</p>
            <p>Maintaining a strong sense of community remains RSBI&#x2019;s fundamental mission. This spirit of community is crucial not only for facilitating training and networking but also for spearheading the adoption of new methodologies. Monthly meetings, annual conferences, training and public engagement events have been and will continue to be effective mechanisms for connecting the community. Alongside these, the establishment of national communities of practice embedded in the ELIXIR communities is anticipated to accelerate the development of the national bioinformatics capacity. As a transversal organisation, RSBI can act as a unifying force for stakeholders, bringing together diverse parties to facilitate discussions in the best interest of national bioinformatics. RSBI can also play a significant role in strengthening the local community by sustainably connecting Romanian bioinformatics professionals in the diaspora with scientists in the country.</p>
            <p>The training activities are poised to evolve with the adoption of FAIR principles. As high-quality resources become more available, especially through ELIXIR, there is a need to adjust the training model accordingly. The national bioinformatics training program must transition to a more integrated approach, aligning closely with the broader European resources offered by ELIXIR Nodes.</p>
            <p>The engagement with the wider life science community and the public would need to be scaled up. Of note, community engagement and involvement is becoming a prerequisite for major research projects. National professional societies and infrastructures offer the optimal framework for fostering this involvement. RSBI can achieve sustained communication with the general public on a large scale through collaborations with other organisations.</p>
            <p>The evolution of bioinformatics as a profession, along with its expanding roles in science and industry, will inevitably raise new ethical considerations. RSBI must gradually transition into assuming the role of an ethics body to address these emerging ethical challenges.</p>
            <p>Importantly, RSBI&#x2019;s activities must be closely linked with those of CRB. Firstly, the infrastructure developed by CRB, and notably the mechanisms to implement FAIR, can be impactful only if adopted by the community. RSBI has the scale and mechanisms to advocate for these principles within the community. Secondly, an ELIXIR Node has the institutional mechanisms to leverage the resources required by RSBI to organise training and public engagement programmes. Finally, the relationship between these two organisations, both developed on ethical principles, offers a framework to maintain checks and balances, ensuring equitable access to resources and appropriate representation of community interests. Although the scope of an ELIXIR Node, which focuses on infrastructure development, differs from that of a national professional organisation, which aims to connect, facilitate career development, and represent the professional community, these entities must work closely, optimise synergies, and manage overlaps.</p>
        </sec>
        <sec id="sec6">
            <title>Author contributions</title>
            <p>BM developed the concept with input from HLB and MA. BM performed the research and prepared the manuscript. DM and MDL prepared the figures included in the manuscript. CZB prepared the Supplementary Material 2. MA, HLB and CZB contributed to the preparation and revision of the manuscript.</p>
        </sec>
    </body>
    <back>
        <sec id="sec9" sec-type="data-availability">
            <title>Data availability</title>
            <sec id="sec10">
                <title>Underlying data</title>
                <p>No data are associated with this article.</p>
            </sec>
            <sec id="sec11">
                <title>Extended data</title>
                <p>Zenodo: Extended Data 1: The list of RoBioinfo Seminars, workshops and webinars organised between November 2017 and April 2024. 
                    <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.13235287">https://doi.org/10.5281/zenodo.13235287</ext-link> (
                    <xref ref-type="bibr" rid="ref26">RSBI, 2024a</xref>).</p>
                <p>This project contains the following extended data:
                    <list list-type="bullet">
                        <list-item>
                            <label>-</label>
                            <p>The RoBioinfo Seminars, workshops and webinars.pdf</p>
                        </list-item>
                    </list>
                </p>
                <p>Zenodo: Extended Data 2: Beer and Science - Public Engagement Toolkit. 
                    <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.13235179">https://doi.org/10.5281/zenodo.13235179</ext-link> (
                    <xref ref-type="bibr" rid="ref27">RSBI, 2024b</xref>).</p>
                <p>This project contains the following extended data:
                    <list list-type="bullet">
                        <list-item>
                            <label>-</label>
                            <p>RSBI Beer and Science toolkit.pdf</p>
                        </list-item>
                    </list>
                </p>
                <p>Zenodo: Extended Data 3: Human Genomics - Public Engagement Leaflets - Romanian. 
                    <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.13150360">https://doi.org/10.5281/zenodo.13150360</ext-link> (
                    <xref ref-type="bibr" rid="ref28">RSBI, 2024c</xref>).</p>
                <p>This project contains the following extended data in Romanian with corresponding ENglish translations: translations:
                    <list list-type="bullet">
                        <list-item>
                            <label>-</label>
                            <p>RSBI Public Engagement leaflet - medical doctors.pdf</p>
                        </list-item>
                        <list-item>
                            <label>-</label>
                            <p>RSBI Public Engagement leaflet - public.pdf</p>
                        </list-item>
                    </list>
                </p>
                <p>Zenodo: Extended Data 4: Data federation advocacy attempts. 
                    <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.13235768">https://doi.org/10.5281/zenodo.13235768</ext-link> (
                    <xref ref-type="bibr" rid="ref29">RSBI, 2024d</xref>)</p>
                <p>This project contains the following extended data:
                    <list list-type="bullet">
                        <list-item>
                            <label>-</label>
                            <p>Data federation advocacy attempts.pdf</p>
                        </list-item>
                    </list>
                </p>
                <p>Data are available under the terms of the 
                    <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link> (CC-BY 4.0).</p>
            </sec>
        </sec>
        <ack>
            <title>Acknowledgements</title>
            <p>The authors wish to acknowledge the following individuals who have played instrumental roles in developing the Romanian Society of Bioinformatics: Khalil Abudahab, Irina Armean, Iuliana Bocicor, Mihai Glon&#x0163;, Eivind Hovig, Claudiu Mih&#x0103;il&#x0103;, Valeriu Ohan, Kjell Petersen, Elena Poenaru, Larisa S&#x00e2;rghie, Robi T&#x0103;cutu, Daniela Zaharie.</p>
        </ack>
        <ref-list>
            <title>References</title>
            <ref id="ref1">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Amid</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pakseresht</surname>
                            <given-names>N</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Silvester</surname>
                            <given-names>N</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The COMPARE Data Hubs.</article-title>
                    <source>

                        <italic toggle="yes">Database J. Biol. Databases Curation.</italic>
</source>
                    <year>2019</year>;<volume>2019</volume>:<fpage>baz136</fpage>.
                    <pub-id pub-id-type="pmid">31868882</pub-id>
                    <pub-id pub-id-type="doi">10.1093/database/baz136</pub-id>
                    <pub-id pub-id-type="pmcid">PMC6927095</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref2">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Barker</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Chue Hong</surname>
                            <given-names>NP</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Katz</surname>
                            <given-names>DS</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Introducing the FAIR Principles for research software.</article-title>
                    <source>

                        <italic toggle="yes">Sci. Data.</italic>
</source>
                    <year>2022</year>;<volume>9</volume>:<fpage>622</fpage>.
                    <pub-id pub-id-type="pmid">36241754</pub-id>
                    <pub-id pub-id-type="doi">10.1038/s41597-022-01710-x</pub-id>
                    <pub-id pub-id-type="pmcid">PMC9562067</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref3">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Budd</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Corpas</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Brazas</surname>
                            <given-names>MD</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>A Quick Guide for Building a Successful Bioinformatics Community.</article-title>
                    <source>

                        <italic toggle="yes">PLoS Comput. Biol.</italic>
</source>
                    <year>2015</year>;<volume>11</volume>:<fpage>e1003972</fpage>.
                    <pub-id pub-id-type="pmid">25654371</pub-id>
                    <pub-id pub-id-type="doi">10.1371/journal.pcbi.1003972</pub-id>
                    <pub-id pub-id-type="pmcid">PMC4318577</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref4">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Crosswell</surname>
                            <given-names>LC</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Thornton</surname>
                            <given-names>JM</given-names>
                        </name>
</person-group>:
                    <article-title>ELIXIR: a distributed infrastructure for European biological data.</article-title>
                    <source>

                        <italic toggle="yes">Trends Biotechnol.</italic>
</source>
                    <year>2012</year>;<volume>30</volume>:<fpage>241</fpage>&#x2013;<lpage>242</lpage>.
                    <pub-id pub-id-type="pmid">22417641</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.tibtech.2012.02.002</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref5">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Crusoe</surname>
                            <given-names>MR</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Abeln</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Iosup</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Methods Included: Standardizing Computational Reuse and Portability with the Common Workflow Language.</article-title>
                    <source>

                        <italic toggle="yes">Commun. ACM.</italic>
</source>
                    <year>2022</year>;<volume>65</volume>:<fpage>54</fpage>&#x2013;<lpage>63</lpage>.
                    <pub-id pub-id-type="doi">10.1145/3486897</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref6">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Di Tommaso</surname>
                            <given-names>P</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Chatzou</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Floden</surname>
                            <given-names>EW</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Nextflow enables reproducible computational workflows.</article-title>
                    <source>

                        <italic toggle="yes">Nat. Biotechnol.</italic>
</source>
                    <year>2017</year>;<volume>35</volume>:<fpage>316</fpage>&#x2013;<lpage>319</lpage>.
                    <pub-id pub-id-type="pmid">28398311</pub-id>
                    <pub-id pub-id-type="doi">10.1038/nbt.3820</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref7">
                <mixed-citation publication-type="book">
                    <collab>ELIXIR</collab>:
                    <source>

                        <italic toggle="yes">Webinar series: National bioinformatics communities in ELIXIR.</italic>
</source>
                    <publisher-name>ELIXIR</publisher-name>;<year>2020</year>. [WWW Document]. (accessed 4.30.24).
                    <ext-link ext-link-type="uri" xlink:href="https://elixir-europe.org/events/webinar-elixir-romania">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref8">
                <mixed-citation publication-type="book">
                    <collab>ELIXIR</collab>:
                    <source>

                        <italic toggle="yes">Romania joins ELIXIR as Observer [WWW Document].</italic>
</source>
                    <publisher-name>ELIXIR</publisher-name>;<year>2023</year>. (accessed 4.30.24).
                    <ext-link ext-link-type="uri" xlink:href="https://elixir-europe.org/news/romania-joins-elixir">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref9">
                <mixed-citation publication-type="book">
                    <collab>ELIXIR</collab>:
                    <source>

                        <italic toggle="yes">ELIXIR Romania Webinar [WWW Document].</italic>
</source>
                    <publisher-name>ELIXIR</publisher-name>;<year>2024</year>. (accessed 4.30.24).
                    <ext-link ext-link-type="uri" xlink:href="https://elixir-europe.org/events/elixir-romania-webinar">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref10">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Freeberg</surname>
                            <given-names>MA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Fromont</surname>
                            <given-names>LA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>D&#x2019;Altri</surname>
                            <given-names>T</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The European Genome-phenome Archive in 2021.</article-title>
                    <source>

                        <italic toggle="yes">Nucleic Acids Res.</italic>
</source>
                    <year>2021</year>;<volume>50</volume>:<fpage>D980</fpage>&#x2013;<lpage>D987</lpage>.
                    <pub-id pub-id-type="pmid">34791407</pub-id>
                    <pub-id pub-id-type="doi">10.1093/nar/gkab1059</pub-id>
                    <pub-id pub-id-type="pmcid">PMC8728218</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref11">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Ga&#x00eb;ta</surname>
                            <given-names>BA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Rivas</surname>
                            <given-names>JDL</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Horton</surname>
                            <given-names>P</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Ten simple rules for forming a scientific professional society.</article-title>
                    <source>

                        <italic toggle="yes">PLoS Comput. Biol.</italic>
</source>
                    <year>2017</year>;<volume>13</volume>:<fpage>e1005226</fpage>.
                    <pub-id pub-id-type="pmid">28333920</pub-id>
                    <pub-id pub-id-type="doi">10.1371/journal.pcbi.1005226</pub-id>
                    <pub-id pub-id-type="pmcid">PMC5363797</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref12">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Garcia</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Batut</surname>
                            <given-names>B</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Burke</surname>
                            <given-names>ML</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Ten simple rules for making training materials FAIR.</article-title>
                    <source>

                        <italic toggle="yes">PLoS Comput. Biol.</italic>
</source>
                    <year>2020</year>;<volume>16</volume>:<fpage>e1007854</fpage>.
                    <pub-id pub-id-type="pmid">32437350</pub-id>
                    <pub-id pub-id-type="doi">10.1371/journal.pcbi.1007854</pub-id>
                    <pub-id pub-id-type="pmcid">PMC7241697</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref13">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Georgescu</surname>
                            <given-names>I</given-names>
                        </name>
</person-group>:
                    <article-title>How a one-off public engagement event turned into an international science festival.</article-title>
                    <source>

                        <italic toggle="yes">Nat. Rev. Phys.</italic>
</source>
                    <year>2023</year>;<volume>5</volume>:<fpage>265</fpage>&#x2013;<lpage>266</lpage>.
                    <pub-id pub-id-type="doi">10.1038/s42254-023-00577-0</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref14">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Goble</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Cohen-Boulakia</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Soiland-Reyes</surname>
                            <given-names>S</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>FAIR Computational Workflows.</article-title>
                    <source>

                        <italic toggle="yes">Data Intell.</italic>
</source>
                    <year>2020</year>;<volume>2</volume>:<fpage>108</fpage>&#x2013;<lpage>121</lpage>.
                    <pub-id pub-id-type="doi">10.1162/dint_a_00033</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref15">
                <mixed-citation publication-type="other">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Goble</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Soiland-Reyes</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Bacall</surname>
                            <given-names>F</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Implementing FAIR Digital Objects in the EOSC-Life Workflow Collaboratory.</article-title>
                    <source>

                        <italic toggle="yes">Zenodo.</italic>
</source>
                    <year>2021</year>.
                    <pub-id pub-id-type="doi">10.5281/zenodo.4605654</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref16">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Harrison</surname>
                            <given-names>PW</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lopez</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Rahman</surname>
                            <given-names>N</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The COVID-19 Data Portal: accelerating SARS-CoV-2 and COVID-19 research through rapid open access data sharing.</article-title>
                    <source>

                        <italic toggle="yes">Nucleic Acids Res.</italic>
</source>
                    <year>2021</year>;<volume>49</volume>:<fpage>W619</fpage>&#x2013;<lpage>W623</lpage>.
                    <pub-id pub-id-type="pmid">34048576</pub-id>
                    <pub-id pub-id-type="doi">10.1093/nar/gkab417</pub-id>
                    <pub-id pub-id-type="pmcid">PMC8218199</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref17">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Harrow</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Drysdale</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Smith</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>ELIXIR: providing a sustainable infrastructure for life science data at European scale.</article-title>
                    <source>

                        <italic toggle="yes">Bioinformatics.</italic>
</source>
                    <year>2021</year>;<volume>37</volume>:<fpage>2506</fpage>&#x2013;<lpage>2511</lpage>.
                    <pub-id pub-id-type="pmid">34175941</pub-id>
                    <pub-id pub-id-type="doi">10.1093/bioinformatics/btab481</pub-id>
                    <pub-id pub-id-type="pmcid">PMC8388016</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref18">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Mourad</surname>
                            <given-names>TM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>McNulty</surname>
                            <given-names>AF</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Liwosz</surname>
                            <given-names>D</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The Role of a Professional Society in Broadening Participation in Science: A National Model for Increasing Persistence.</article-title>
                    <source>

                        <italic toggle="yes">Bioscience.</italic>
</source>
                    <year>2018</year>;<volume>68</volume>:<fpage>715</fpage>&#x2013;<lpage>721</lpage>.
                    <pub-id pub-id-type="doi">10.1093/biosci/biy066</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref19">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Patel</surname>
                            <given-names>B</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Soundarajan</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>M&#x00e9;nager</surname>
                            <given-names>H</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Making Biomedical Research Software FAIR: Actionable Step-by-step Guidelines with a User-support Tool.</article-title>
                    <source>

                        <italic toggle="yes">Sci. Data.</italic>
</source>
                    <year>2023</year>;<volume>10</volume>:<fpage>557</fpage>.
                    <pub-id pub-id-type="pmid">37612312</pub-id>
                    <pub-id pub-id-type="doi">10.1038/s41597-023-02463-x</pub-id>
                    <pub-id pub-id-type="pmcid">PMC10447492</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref20">
                <mixed-citation publication-type="other">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Pico</surname>
                            <given-names>EM</given-names>
                            <prefix>del</prefix>
                        </name>

                        <name name-style="western">
                            <surname>Gelpi</surname>
                            <given-names>JL</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Capella-Guti&#x00e9;rrez</surname>
                            <given-names>S</given-names>
                        </name>
</person-group>:
                    <article-title>FAIRsoft - A practical implementation of FAIR principles for research software.</article-title>
                    <year>2022</year>.
                    <pub-id pub-id-type="doi">10.1101/2022.05.04.490563</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref21">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Rocca-Serra</surname>
                            <given-names>P</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Gu</surname>
                            <given-names>W</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ioannidis</surname>
                            <given-names>V</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The FAIR Cookbook - the essential resource for and by FAIR doers.</article-title>
                    <source>

                        <italic toggle="yes">Sci. Data.</italic>
</source>
                    <year>2023</year>;<volume>10</volume>:<fpage>292</fpage>.
                    <pub-id pub-id-type="pmid">37208467</pub-id>
                    <pub-id pub-id-type="doi">10.1038/s41597-023-02166-3</pub-id>
                    <pub-id pub-id-type="pmcid">PMC10198982</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref22">
                <mixed-citation publication-type="other">
                    <collab>Romanian Government</collab>:
                    <article-title>1 Million Genomes Memorandum - Romanian Government [WWW Document].</article-title>
                    <year>2023</year>. (accessed 4.30.24).
                    <ext-link ext-link-type="uri" xlink:href="https://sgg.gov.ro/1/wp-content/uploads/2023/05/MEMO-9.pdf">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref23">
                <mixed-citation publication-type="other">
                    <collab>RSBI</collab>:
                    <article-title>RSBI Facebook Profile.</article-title>
                    <year>2018a</year>.
                    <ext-link ext-link-type="uri" xlink:href="https://www.facebook.com/RoBioinfo">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref24">
                <mixed-citation publication-type="other">
                    <collab>RSBI</collab>:
                    <article-title>RSBI LinkedIn Profile.</article-title>
                    <year>2018b</year>.
                    <ext-link ext-link-type="uri" xlink:href="https://www.linkedin.com/company/robioinfo">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref25">
                <mixed-citation publication-type="other">
                    <collab>RSBI</collab>:
                    <article-title>Press release &#x2013; Romanian Society of Bioinformatics [WWW Document].</article-title>
                    <year>2023</year>. (accessed 4.30.24).
                    <ext-link ext-link-type="uri" xlink:href="https://rsbi.ro/resurse/elixir/comunicat-de-presa/">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref26">
                <mixed-citation publication-type="data">
                    <collab>RSBI</collab>:
                    <data-title>Extended Data 1: The list of RoBioinfo Seminars, workshops and webinars organised between November 2017 and April 2024.</data-title>[Dataset].
                    <source>

                        <italic toggle="yes">Zenodo.</italic>
</source>
                    <year>2024a</year>.
                    <pub-id pub-id-type="doi">10.5281/zenodo.13235287</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref27">
                <mixed-citation publication-type="data">
                    <collab>RSBI</collab>:
                    <data-title>Extended Data 2: Beer and Science - Public Engagement Toolkit.</data-title>[Dataset].
                    <source>

                        <italic toggle="yes">Zenodo.</italic>
</source>
                    <year>2024b</year>.
                    <pub-id pub-id-type="doi">10.5281/zenodo.13235179</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref28">
                <mixed-citation publication-type="data">
                    <collab>RSBI</collab>:
                    <data-title>Extended Data 3: Human Genomics - Public Engagement Leaflets.</data-title>[Dataset].
                    <source>

                        <italic toggle="yes">Zenodo.</italic>
</source>
                    <year>2024c</year>.
                    <pub-id pub-id-type="doi">10.5281/zenodo.13150360</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref29">
                <mixed-citation publication-type="data">
                    <collab>RSBI</collab>:
                    <data-title>Extended Data 4: Data federation advocacy attempts.</data-title>[Dataset].
                    <source>

                        <italic toggle="yes">Zenodo.</italic>
</source>
                    <year>2024d</year>.
                    <pub-id pub-id-type="doi">10.5281/zenodo.13235768</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref30">
                <mixed-citation publication-type="other">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Soranzo</surname>
                            <given-names>N</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Goble</surname>
                            <given-names>C</given-names>
                        </name>
</person-group>:
                    <article-title>BioFAIR: a new BioCommons infrastructure for UK life science.</article-title>
                    <year>2023</year>.
                    <pub-id pub-id-type="doi">10.5281/zenodo.7708304</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref31">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Suddaby</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Greenwood</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Hinings</surname>
                            <given-names>C</given-names>
                        </name>
</person-group>:
                    <article-title>Theorizing Change: The Role of Professional Associations in the Transformation of Institutionalized Fields.</article-title>
                    <source>

                        <italic toggle="yes">Acad. Manag. J.</italic>
</source>
                    <year>2002</year>;<volume>45</volume>:<fpage>58</fpage>&#x2013;<lpage>80</lpage>.
                    <pub-id pub-id-type="doi">10.2307/3069285</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref32">
                <mixed-citation publication-type="journal">
                    <collab>The Galaxy Community</collab>:
                    <article-title>The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update.</article-title>
                    <source>

                        <italic toggle="yes">Nucleic Acids Res.</italic>
</source>
                    <year>2022</year>;<volume>50</volume>:<fpage>W345</fpage>&#x2013;<lpage>W351</lpage>.
                    <pub-id pub-id-type="pmid">35446428</pub-id>
                    <pub-id pub-id-type="doi">10.1093/nar/gkac247</pub-id>
                    <pub-id pub-id-type="pmcid">PMC9252830</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref33">
                <mixed-citation publication-type="other">
                    <collab>UEFISCDI, RSBI</collab>:
                    <article-title>COVID19 Portal for Scientific Information [WWW Document].</article-title>
                    <year>2020</year>. (accessed 4.30.24).
                    <ext-link ext-link-type="uri" xlink:href="https://uefiscdi.gov.ro/uefiscdi-si-rsbi-colaboreaza-in-cadrul-covid-19-research-hub-0">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref34">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Wilkinson</surname>
                            <given-names>MD</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Dumontier</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Aalbersberg</surname>
                            <given-names>IJJ</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The FAIR Guiding Principles for scientific data management and stewardship.</article-title>
                    <source>

                        <italic toggle="yes">Sci. Data.</italic>
</source>
                    <year>2016</year>;<volume>3</volume>:<fpage>160018</fpage>.
                    <pub-id pub-id-type="pmid">26978244</pub-id>
                    <pub-id pub-id-type="doi">10.1038/sdata.2016.18</pub-id>
                    <pub-id pub-id-type="pmcid">PMC4792175</pub-id>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
    <sub-article article-type="reviewer-report" id="report321799">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.168851.r321799</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Goble</surname>
                        <given-names>Carol</given-names>
                    </name>
                    <xref ref-type="aff" rid="r321799a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0003-1219-2137</uri>
                </contrib>
                <aff id="r321799a1">
                    <label>1</label>The University of Manchester, Manchester, England, UK</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>12</day>
                <month>10</month>
                <year>2024</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2024 Goble C</copyright-statement>
                <copyright-year>2024</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport321799" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.153895.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>The paper is two parts, both concerning the establishment of a bioinformatics national community in Romania. The first part describes how and why a professional society was established; the second the steps towards a national node of the ELIXIR research infrastructure.</p>
            <p> </p>
            <p> The article is informative and quite well written and describes the high level vision and the steps taken.</p>
            <p> </p>
            <p> As an opinion piece it is short on opinion. It is unclear if the objective is to provide an announcement of the establishment of a society and an ELIXIR Node, or if there is some more significant discussion regarding the specific challenges within Romania or lessons that other countries might learn. 
                <list list-type="bullet">
                    <list-item>
                        <p>Some clarity is needed in what is meant by a &#x201c;national bioinformatics infrastructure&#x201d;, which in this case is an ELIXIR Node. What an ELIXIR Node is, and the many forms of Nodes (there are 25 nodes including Romania) needs to be better described &#x2013; most readers will not know. The term &#x201c;infrastructure is open to interpretation</p>
                    </list-item>
                    <list-item>
                        <p>In what way does the RSBI differ from other National societies? What did you find useful and less useful from using the guidelines you cite?</p>
                    </list-item>
                    <list-item>
                        <p>What are the unique or special offerings of the Romanian Node to ELIXIR and what does Romania need for its bioinformatics community? There are 30+ communities and focus groups in ELIXIR &#x2013; which ones are strengths or beneficial growth areas for Romania? The objectives of the CRB are rather high level and non-national specific. Does Romania have strengths in areas of rare disease, precision medicine, agritech, structiural bioinformatics, e-learning, AI etc</p>
                    </list-item>
                    <list-item>
                        <p>What is the scale of a country-wide network of bioinformaticians?&#x00a0; How many people? Data services? There are 17 organisations &#x2013; are these funded as a network like ELIXIR UK or as a funded programme of joint work like ELIXIR-CZ? Is the CRB supported by a national award or subscriptions or in kind?</p>
                    </list-item>
                    <list-item>
                        <p>Data federation takes many forms and is complex (it is not just FEGA) &#x2013; two paragraphs are unclear what federation was expected or tried.</p>
                    </list-item>
                    <list-item>
                        <p>A national ELIXIR Node is expected to interact with other nodes. Training with Hungary and Poland was mentioned and participation in GDI. Are here other opportunities given your CRB objectives?</p>
                    </list-item>
                </list> In summary the paper would benefit from a clearer statement of its message and a clearer statement on the national needs and national resources. &#x00a0;It can also provide useful critical insights on the challenges and resources needed to establish a national infrastructure useful for other nations.</p>
            <p> Minor points</p>
            <p> Introduction 
                <list list-type="bullet">
                    <list-item>
                        <p>The introduction&#x2019;s history of ELIXIR should add that it was founded in 2013. It isn&#x2019;t clear what is meant by &#x201c;second phase&#x201d; and I suggest you drop this phrase.</p>
                    </list-item>
                    <list-item>
                        <p>The projects GDI, EOSC-ENTRUST should be cited. The sentence that these projects &#x201c;reply on these structures for their European and national reach&#x201d; is unclear. Do you mean they rely on national nodes? It is not clear who &#x201c;these structures&#x201d; and &#x201c;they&#x201d; refers to.&#x00a0;</p>
                    </list-item>
                    <list-item>
                        <p>National infrastructures were identified as &#x201c;adequate&#x201d; mechanisms is a strange statement. Needed or necessary or just mechanisms, perhaps.</p>
                    </list-item>
                    <list-item>
                        <p>Figure 1 is useful but too busy to read</p>
                    </list-item>
                    <list-item>
                        <p>Figure 2 A is unnecessary</p>
                    </list-item>
                </list>
            </p>
            <p>Is the topic of the opinion article discussed accurately in the context of the current literature?</p>
            <p>Yes</p>
            <p>Are arguments sufficiently supported by evidence from the published literature?</p>
            <p>Yes</p>
            <p>Are all factual statements correct and adequately supported by citations?</p>
            <p>Yes</p>
            <p>Are the conclusions drawn balanced and justified on the basis of the presented arguments?</p>
            <p>Partly</p>
            <p>Reviewer Expertise:</p>
            <p>NA</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
        <sub-article article-type="response" id="comment15281-321799">
            <front-stub>
                <contrib-group>
                    <contrib contrib-type="author">
                        <name>
                            <surname>Mirauta</surname>
                            <given-names>Bogdan</given-names>
                        </name>
                        <aff>Romanian Bioinformatics Cluster, Targu Mures, Romania</aff>
                    </contrib>
                </contrib-group>
                <author-notes>
                    <fn fn-type="conflict">
                        <p>
                            <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                    </fn>
                </author-notes>
                <pub-date pub-type="epub">
                    <day>15</day>
                    <month>1</month>
                    <year>2026</year>
                </pub-date>
            </front-stub>
            <body>
                <p>We thank the reviewer for the detailed and constructive feedback.&#x00a0;We delayed submitting our responses in the expectation that the process of ELIXIR membership for Romania, one of the important outcomes documented in this article, would be finalized; however, the Romanian Parliament&#x2019;s decision required under Romanian law has taken longer than anticipated and is currently pending in February&#x00a0; 2026.</p>
                <p> </p>
                <p> While this extended the response timeline, it allowed us to address an important request from the reviewers. Following the reviewers&#x2019; suggestions to address the bioinformatics resources in Romania, we have launched the initial version of the Catalogue of Romanian Bioinformatics Services (CaRoBioS; 
                    <ext-link ext-link-type="uri" xlink:href="https://bioinfocluster.ro/services/carobios">https://bioinfocluster.ro/services/carobios</ext-link>), in which the first resources have recently undergone peer review. This live, peer-reviewed registry will contribute to a reliable description of the bioinformatics portfolio and help identify the specific contributions of Romanian bioinformatics to ELIXIR.</p>
                <p> </p>
                <p> In addition, we have clarified the scope of the paper by adding a dedicated paragraph at the end of the Introduction. While one objective of this article is to facilitate the establishment of the Romanian ELIXIR Node (CRB), we note that its main purpose is to document the historical activities of the professional organization Romanian Society of Bioinformatics (RSBI), providing a record that is important for understanding the community&#x2019;s longstanding engagement, guiding future initiatives, and informing policymakers and funders about the evolution of bioinformatics in Romania. Additionally, we clarified that the Romanian ELIXIR Node is forthcoming and has not yet been established.</p>
                <p> </p>
                <p> </p>
                <p> 
                    <bold>Additional major comments</bold>
                </p>
                <p> </p>
                <p> We thank the reviewer for highlighting the need to clarify the Romania&#x2019;s role in ELIXIR. We have added a paragraph addressing some of the objectives for the Romanian Node but did not address its contribution in the wider ELIXIR network. We note that, as the ELIXIR membership process is not yet finalized, we cannot yet accurately address points related to Romania&#x2019;s contributions within ELIXIR. However, we have developed CaRoBios, a registry of resources, that will likely help identifying resources that can benefit the wider network. We note that one of the criteria used in evaluating these resources is their potential within&#x00a0; ELIXIR.</p>
                <p> </p>
                <p> Similarly, to address the question &#x201c;what is meant by a national bioinformatics infrastructure&#x201d;, an unequivocal definition will be provided once the ELIXIR membership process is finalized. However, RSBI made significant steps in defining this infrastructure by establishing its administrative structure, i.e CRB, a consortium with legal status, and identifying the priorities in terms of data, tools and training.&#x00a0;</p>
                <p> </p>
                <p> We also wish to clarify that, at present, neither CRB nor RSBI receives dedicated core funding. CRB&#x2019;s future funding opportunities are largely contingent on the Parliament&#x2019;s approval of ELIXIR membership, while RSBI is primarily funded through member fees.&#x00a0;</p>
                <p> </p>
                <p> At the beginning of the Discussion section, we added information on our estimate of the size of the bioinformatics-dedicated community in Romania. Although this estimate is approximate, it provides readers with a clearer understanding of the community&#x2019;s current scale and its potential for future development.</p>
                <p> </p>
                <p> Regarding potential interactions between CRB (as the main candidate for Romania&#x2019;s ELIXIR Node) and other ELIXIR Nodes, these are highly dependent on the completion of the ELIXIR membership process for Romania. Institutional interactions are expected primarily at the CRB level rather than at the level of the professional society. We would also like to emphasize that this paper focuses on the role of professional society RSBI in developing the national bioinformatics ecosystem; therefore, future interactions at the CRB level are beyond the scope of this manuscript.&#x00a0;</p>
                <p> </p>
                <p> Regarding data federation, we acknowledge that it is a complex concept with multiple possible implementations and that it offers clear benefits across many domains beyond the well-established human &#x2019;omics&#x2013;related use cases. While valuable lessons were learned from the exploratory efforts described in this paper, we are unable to provide further details on this topic at this stage.</p>
                <p> </p>
                <p> We agree with the reviewer on the importance of highlighting the most relevant elements of the cited guidelines and direct the reviewer to the discussion in the first paragraph of the section &#x201c;Conclusions on the Establishment of the National Professional Society&#x201d;.</p>
                <p> </p>
                <p> 
                    <bold>Minor comments&#x00a0;</bold>
                </p>
                <p> </p>
                <p> We have addressed the minor points raised by the reviewer by adding the ELIXIR foundation year, clarifying the phrasing regarding how GDI and EOSC&#x2011;ENTRUST leverage established pan-European infrastructures, including references to these projects, simplifying the contents of Figure 1 and implementing other minor revisions.</p>
            </body>
        </sub-article>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report321795">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.168851.r321795</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Zambelli</surname>
                        <given-names>Federico</given-names>
                    </name>
                    <xref ref-type="aff" rid="r321795a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0003-3487-4331</uri>
                </contrib>
                <aff id="r321795a1">
                    <label>1</label>University of Milan, Milan, Italy</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>30</day>
                <month>9</month>
                <year>2024</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2024 Zambelli F</copyright-statement>
                <copyright-year>2024</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport321795" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.153895.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>The authors outline the establishment of the Romanian Society of Bioinformatics and the efforts towards building a national biological data infrastructure, including the formation of a tentative ELIXIR Node.&#x00a0;</p>
            <p> </p>
            <p> Many of the problems and hurdles in the process are common with other countries, including the difficulty of interacting with policymakers and decision-making bodies to establish clear road maps, which are critical components in the construction and maintenance of any infrastructure, including those dedicated to scientific data.</p>
            <p> </p>
            <p> The manuscript does a good job of describing Romanian bioinformatics' current situation and ambition, and the initiative's promoters are to be commended for their efforts in integrating national efforts in the European context. However, a more in-depth description of the current bioinformatics portfolio of resources, services, industry interactions (if any), interests, main actors, and expertise in Romania would help the reader understand the sector's growth potential in the country.</p>
            <p>Is the topic of the opinion article discussed accurately in the context of the current literature?</p>
            <p>Yes</p>
            <p>Are arguments sufficiently supported by evidence from the published literature?</p>
            <p>Yes</p>
            <p>Are all factual statements correct and adequately supported by citations?</p>
            <p>Yes</p>
            <p>Are the conclusions drawn balanced and justified on the basis of the presented arguments?</p>
            <p>Yes</p>
            <p>Reviewer Expertise:</p>
            <p>Bioinformatics, transcriptomics, epigenomics, research infrastructures, cloud computing.</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
        <sub-article article-type="response" id="comment15280-321795">
            <front-stub>
                <contrib-group>
                    <contrib contrib-type="author">
                        <name>
                            <surname>Mirauta</surname>
                            <given-names>Bogdan</given-names>
                        </name>
                        <aff>Romanian Bioinformatics Cluster, Targu Mures, Romania</aff>
                    </contrib>
                </contrib-group>
                <author-notes>
                    <fn fn-type="conflict">
                        <p>
                            <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                    </fn>
                </author-notes>
                <pub-date pub-type="epub">
                    <day>15</day>
                    <month>1</month>
                    <year>2026</year>
                </pub-date>
            </front-stub>
            <body>
                <p>We thank the reviewer for their insightful comments and for recognizing the challenges faced in establishing a national bioinformatics infrastructure, including interactions with policymakers and decision-making bodies.</p>
                <p> </p>
                <p> We delayed submitting our responses in the expectation that the process of ELIXIR membership for Romania, one of the important outcomes documented in this article, would be finalized; however, the Romanian Parliament&#x2019;s decision required under Romanian law has taken longer than anticipated and is currently pending in February 2026.</p>
                <p> </p>
                <p> While this extended the response timeline, it allowed us to address an important request from the reviewers. Following the reviewer's suggestion to address the portfolio of bioinformatics resources in Romania, we have launched the initial version of the Catalogue of Romanian Bioinformatics Services (CaRiBioS; 
                    <ext-link ext-link-type="uri" xlink:href="https://bioinfocluster.ro/services/carobios">https://bioinfocluster.ro/services/carobios</ext-link>), in which the first resources have recently undergone peer review. This live, peer-reviewed registry will contribute to a reliable description of the bioinformatics portfolio and help identify the specific contributions of Romanian bioinformatics to ELIXIR. We note that, although rigorously developed, the catalogue is still in its early stages, with the first evaluated resources added in December 2025, and therefore it does not yet provide an exhaustive list of Romanian bioinformatics resources. We have added a paragraph describing CaRoBioS in the manuscript.</p>
            </body>
        </sub-article>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report321797">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.168851.r321797</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Ouellette</surname>
                        <given-names>Francis</given-names>
                    </name>
                    <xref ref-type="aff" rid="r321797a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0003-4676-675X</uri>
                </contrib>
                <aff id="r321797a1">
                    <label>1</label>Bioinformatics, Montreal, Canada</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>25</day>
                <month>9</month>
                <year>2024</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2024 Ouellette F</copyright-statement>
                <copyright-year>2024</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport321797" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.153895.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>The authors of the opinion article "From the Establishment of a National Bioinformatics Society to the Development of a National Bioinformatics Infrastructure" present the evolution of a bioinformatics national community. They describe the existing bioinformatics infrastructure that the Romanian national bioinformatics community will use. This opinion is part of their process to establish and evolve the Romanian Node into a full member of &#x00a0;Elixir Europe.&#x00a0;</p>
            <p> </p>
            <p> This opinion piece should expand on and clarify a few points. These comments are made in light of the nature of this submission: it is the expression of the author's opinion, not mine.&#x00a0;</p>
            <p> </p>
            <p> 1. This article is well-written, but the underlying objectives need to be clarified. This position paper would be more explicit to the reader if the authors expressed their intent to develop a national bioinformatics infrastructure and why they are doing what they describe.</p>
            <p> </p>
            <p> 2. Knowing the reading audience is essential to consider when writing this opinion. If the audience is complex and diverse (e.g., politicians, senior biologists, new computer scientists, and trainees), you may need to target some sections for each audience. &#x00a0;</p>
            <p> </p>
            <p> 3. Another important point:</p>
            <p> Are there particular biological questions that need to be answered by this community?</p>
            <p> Do they need trained bioinformaticians, dedicated resources, cloud computing, specific tools, or specialized databases to answer these questions?</p>
            <p> Is there a need for the medical community to be able to interpret human genomes?</p>
            <p> Specific environmental microbiomes?</p>
            <p> Do veterinarians need to understand and deal with specific outbreaks?</p>
            <p> Do farmers have specific pest management challenges resulting from global warming they have never anticipated?</p>
            <p> Are the current biology and health sciences programs ill-equipped to address these challenges?</p>
            <p> </p>
            <p> If so, the community may need to train bioinformatics people at all levels (undergraduates, graduate, post-doc, and professional development programs), and for that work to get done, you will also need funding (scale of funding necessary). An opinion piece like this one is an opportunity to explain what the needs are, how to achieve these needs and defend the budget necessary to make this possible.&#x00a0;</p>
            <p> </p>
            <p> 
                <bold>Comments about the figures:</bold>
            </p>
            <p> </p>
            <p> 4. Figure 1: The idea of a timeline is excellent. This timeline represents many of the items detailed in the text. The figure has too much text and should be redone with one or two points for each critical time point. Can a reference tag be used in the text? I am unsure about the rules for this journal, but it might be useful to consider a separate table with all the acronyms used in this opinion. &#x00a0;</p>
            <p> </p>
            <p> 5. Figure 2 A: This figure (2A) is not helpful here. It repeats much of the text in the opinion piece.</p>
            <p> </p>
            <p> 6. Figure 2 B: Maps are great information tools, but could this information also be useful in a table?</p>
            <p> </p>
            <p> 1- City</p>
            <p> 2- Name of university/Institution/company (with URL)</p>
            <p> 3- Department(s) involved</p>
            <p> 4- Bioinformatics expertise (maybe develop 5 or 6 codes for different disciplines?&#x00a0;</p>
            <p> &#x00a0; &#x00a0; Medical genetics, Computer Assisted Drug&#x00a0;</p>
            <p> &#x00a0; &#x00a0; development, HPC, Database or Algorithm development or any other&#x00a0;</p>
            <p> &#x00a0; &#x00a0; specialities.&#x00a0;</p>
            <p> 5- Human-centric? Plant? Vetenary? Prokaryotic? Viruses? Ecology? Medicine?</p>
            <p> 6- Number of scientists involved in this community (group leader/trainees?) at this institution.</p>
            <p> </p>
            <p> Then, on this map, you could mark the cities (with orange counties where such institutions reside, as you have it now), and with this table, it would be a good community status at this point. Over the years, you could show a growing orange wave across Romania!</p>
            <p>Is the topic of the opinion article discussed accurately in the context of the current literature?</p>
            <p>Yes</p>
            <p>Are arguments sufficiently supported by evidence from the published literature?</p>
            <p>Yes</p>
            <p>Are all factual statements correct and adequately supported by citations?</p>
            <p>Yes</p>
            <p>Are the conclusions drawn balanced and justified on the basis of the presented arguments?</p>
            <p>Partly</p>
            <p>Reviewer Expertise:</p>
            <p>Computational biologist, member of the Elixir SAB for the last 8 years.</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
        <sub-article article-type="response" id="comment15279-321797">
            <front-stub>
                <contrib-group>
                    <contrib contrib-type="author">
                        <name>
                            <surname>Mirauta</surname>
                            <given-names>Bogdan</given-names>
                        </name>
                        <aff>Romanian Bioinformatics Cluster, Targu Mures, Romania</aff>
                    </contrib>
                </contrib-group>
                <author-notes>
                    <fn fn-type="conflict">
                        <p>
                            <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                    </fn>
                </author-notes>
                <pub-date pub-type="epub">
                    <day>15</day>
                    <month>1</month>
                    <year>2026</year>
                </pub-date>
            </front-stub>
            <body>
                <p>We thank the reviewers for their comments. We delayed submitting our responses in the expectation that the process of ELIXIR membership for Romania, one of the important outcomes documented in this article, would be finalized; however, the Romanian Parliament&#x2019;s decision required under Romanian law has taken longer than anticipated and is currently pending in February&#x00a0; 2026.</p>
                <p> </p>
                <p> While this extended the response timeline, it allowed us to address an important request from the reviewers. Following the reviewers&#x2019; suggestions to address the bioinformatics resources in Romania, we have launched the initial version of the Catalogue of Romanian Bioinformatics Services (CaRiBioS; 
                    <ext-link ext-link-type="uri" xlink:href="https://bioinfocluster.ro/services/carobios">https://bioinfocluster.ro/services/carobios</ext-link>), in which the first resources have recently undergone peer review. This live, peer-reviewed registry will contribute to a reliable description of the bioinformatics portfolio and help identify the specific contributions of Romanian bioinformatics to ELIXIR.</p>
                <p> </p>
                <p> In addition, we have clarified the scope of the paper by adding a dedicated paragraph at the end of the Introduction. While one objective of this article is to facilitate the establishment of the Romanian ELIXIR Node (CRB), we note that its main purpose is to document the historical activities of the professional organization Romanian Society of Bioinformatics (RSBI), providing a record that is important for understanding the community&#x2019;s longstanding engagement, guiding future initiatives, and informing policymakers and funders about the evolution of bioinformatics in Romania. Additionally, we clarified that the Romanian ELIXIR Node is forthcoming and has not yet been established.</p>
                <p> </p>
                <p> 
                    <bold>Comments 1.1, 1.2</bold>
                </p>
                <p> We thank the reviewer for their positive feedback and for highlighting this need to clarify the purpose of the paper. To clarify the objectives of the paper, we have added a dedicated paragraph at the end of the Introduction. This paragraph outlines the rationale of the study and implicitly helps clarify the intended readership.&#x00a0;</p>
                <p> </p>
                <p> 
                    <bold>Comments 1.3 </bold>We thank the reviewer for raising the question of the specific biological questions and training needs of the community. Although we conducted surveys to identify training requirements, the results did not allow us to define precise domain-specific directions, as responses reflected a highly heterogeneous community, including groups working in human &#x2019;omics, plant and animal biology and microorganisms. Nevertheless, we identified several cross-cutting challenges shared across domains, particularly in data management and data access. Accordingly, we have included data stewardship as one of the priorities of the Romanian Cluster of Bioinformatics (CRB) and note that this is also a recognized priority across the wider ELIXIR community. We also point out that the newly launched framework CaRoBioS will result in the medium term in identifying priority areas for Romanian bioinformatics.</p>
                <p> </p>
                <p> 
                    <bold>Comments on figures&#x00a0;</bold>
                </p>
                <p> We thank the reviewer for the suggestion to simplify Figure 1. In response, we have revised the figure and included a new version with substantially reduced text to improve clarity and readability.</p>
                <p> We agree that much of the information shown in Figure 2A is also described in the text. However, we believe that this panel provides a concise visual representation of the chronology leading to potential ELIXIR membership, which facilitates improved understanding of the sustained, long-term commitment of the bioinformatics-dedicated community in Romania.</p>
                <p> While we acknowledge the reviewer&#x2019;s suggestion to present the information shown in Figure 2B in tabular form, we consider that the geographical map more intuitively conveys the national distribution and spatial coverage of CRB member institutions across Romania. We also agree that providing additional details about each institution would be valuable and will consider including these details in a prospective article focused on describing the aims, structure and potential impact of CRB article once the process of Romania&#x2019;s membership to ELIXIR is completed.</p>
            </body>
        </sub-article>
    </sub-article>
</article>
